Abstract
Despite the efforts in controlling the parasite and infection, and the significant progress achieved in recent years in its treatment, malaria is still prevalent in many regions and out of control in others. The repertoire of alternatives to fight malaria is being expanded, not only by designing new drugs but also by developing improved drug delivery systems able to enhance the antimalarial efficiency of conventional and new drugs. Among the new drugs that have been investigated, several publications report the use of porphyrin derivatives as antimalarials but their efficiency is contradictory. The low activity of porphyrins seems to be associated with low dispersibility and bioavailability. In this respect, Nanotechnology can provide efficient solutions to enhance bioavailability and delivery of conventional and new antimalarials, in order to assure high enough efficiency levels to inactivate the parasite. Thus, in this review we highlight the use of drug delivery systems for conventional and new antimalarials and we propose the encapsulation of porphyrins as a promising alternative for development of anti-malarial formulations.
Keywords: Drug delivery systems, malaria, nanotechnology, Plasmodium falciparum, polymeric particles, porphyrins.
Mini-Reviews in Medicinal Chemistry
Title:Strategies for Development of Antimalarials Based on Encapsulated Porphyrin Derivatives
Volume: 14 Issue: 13
Author(s): Daiana K. Deda, Alexandre Budu, Laura N. Cruz, Koiti Araki and Celia R.S. Garcia
Affiliation:
Keywords: Drug delivery systems, malaria, nanotechnology, Plasmodium falciparum, polymeric particles, porphyrins.
Abstract: Despite the efforts in controlling the parasite and infection, and the significant progress achieved in recent years in its treatment, malaria is still prevalent in many regions and out of control in others. The repertoire of alternatives to fight malaria is being expanded, not only by designing new drugs but also by developing improved drug delivery systems able to enhance the antimalarial efficiency of conventional and new drugs. Among the new drugs that have been investigated, several publications report the use of porphyrin derivatives as antimalarials but their efficiency is contradictory. The low activity of porphyrins seems to be associated with low dispersibility and bioavailability. In this respect, Nanotechnology can provide efficient solutions to enhance bioavailability and delivery of conventional and new antimalarials, in order to assure high enough efficiency levels to inactivate the parasite. Thus, in this review we highlight the use of drug delivery systems for conventional and new antimalarials and we propose the encapsulation of porphyrins as a promising alternative for development of anti-malarial formulations.
Export Options
About this article
Cite this article as:
Deda K. Daiana, Budu Alexandre, Cruz N. Laura, Araki Koiti and Garcia R.S. Celia, Strategies for Development of Antimalarials Based on Encapsulated Porphyrin Derivatives, Mini-Reviews in Medicinal Chemistry 2014; 14 (13) . https://dx.doi.org/10.2174/1389557515666150101094829
DOI https://dx.doi.org/10.2174/1389557515666150101094829 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Modulating Poly (ADP-Ribose) Polymerase Activity: Potential for the Prevention and Therapy of Pathogenic Situations Involving DNA Damage and Oxidative Stress
Current Pharmaceutical Biotechnology Personalized Diabetes and Cancer Medicine: A Rationale for Anti-Diabetic Nutrition (Bitter Melon) in a Supportive Setting
Current Cancer Therapy Reviews Metal Oxide Nanoparticles: Potential Uses in Biomedical Applications
Current Proteomics High Throughput Bioassays Using Nanoparticles
Combinatorial Chemistry & High Throughput Screening Review: Alternative Splicing (AS) of Genes As An Approach for Generating Protein Complexity
Current Genomics Enhanced Fluorescence of Curcumin on Plasmonic Platforms
Current Pharmaceutical Biotechnology Precision-Cut Organ Slices as a Tool to Study Toxicity and Metabolism of Xenobiotics with Special Reference to Non-Hepatic Tissues
Current Drug Metabolism Design, Synthesis and Cytotoxic Activity Evaluation of New Aminosubstituted Benzofurans
Medicinal Chemistry Novel Stereoselective Oximes: Their Synthesis and Anti-leishmanials Evaluation
Current Bioactive Compounds Design, Synthesis, Crystal Structure, and Antimicrobial Evaluation of Novel Pyrazolyl-1,3,5-oxadiazoles, Pyrazolyl-1,2,4-triazoles and their Related Thioglycosides
Letters in Drug Design & Discovery Tumour Targeting with Systemically Administered Bacteria
Current Gene Therapy Development of a Sensitive Cost-Effective Capture ELISA for Detection of Murine Monoclonal Antibodies - Correlation with SPR Biosensor Technology
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Polydivinylbenzene Hollow Nanospheres as an Effective Fluorescent Sensing Platform for DNA Detection
Current Nanoscience Protein-Labs on Separative Analytical Scale in Medicinal Chemistry: from the Proof of Concept to Applications
Current Organic Chemistry Non-Traditional Drug Targets: High Risk, High Reward
Current Gene Therapy Development of Aptamer-Based Nanomaterials for Biological Analysis
Current Molecular Medicine Perspectives on Sesquiterpene Lactones in Inflammation and Cancer
Current Drug Targets Microencapsulation: The Emerging Role of Microfluidics
Micro and Nanosystems Chitosan Formulations as Carriers for Therapeutic Proteins
Current Drug Discovery Technologies Loop Transverse Colostomy - A Modified Technique
Combinatorial Chemistry & High Throughput Screening